Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Co-Diagnostics, Inc. (CODX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.7100-0.0500 (-1.33%)
At close: 04:00PM EDT
3.6900 -0.02 (-0.54%)
After hours: 05:38PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • c
    capt
    Half of People With Omicron Don't Know They're Infected, Study Says

    https://news.yahoo.com/half-people-omicron-dont-know-161854173.html
    Bullish
  • d
    dan
    On day you will wake up and bam 💥 $27 share price - buyout is happening
  • x
    xu
    When a company runs high .. mess .. looing for fix ..
    When a company runs low .. efficiency .. looking for growth ..
    Time will tell Co-Dx with more added to menu list and a new product out ..
    CDC telling making mistakes ..
    How about FDA ..
    //
    Kohl's has an inventory mess on its hands
    Parija Kavilanz Byline
    By Parija Kavilanz, CNN Business

    Updated 8:46 AM ET, Fri August 19, 2022
    //
  • R
    Roy
    More odd strange CODX trading share prices this morning. Illegal "matched order" and "washed trades" market manipulation is just getting started.
    ----------
    CODX Latest Pre Market Trades
    Volume: 2,787
    DATA AS OF AUG 18, 2022 8:45 AM ET
    Pre-Market Time (ET) Pre-Market Price Pre-Market Share Volume
    08:21:51 $3.8812 1
    08:21:04 $3.9300 3
    08:00:18 $3.9288 10
    08:00:17 $3.8812 35
    08:00:12 $3.8512 1
    08:00:11 $3.9888 40
    08:00:11 $3.8512 100
    08:00:10 $3.8512 1
    08:00:10 $3.9888 60
    08:00:10 $3.9688 250
    08:00:10 $3.9688 4
    08:00:10 $3.8512 160
    08:00:10 $3.8512 200
    08:00:09 $3.8512 70
    08:00:09 $3.9688 10
    08:00:09 $3.9688 10
    08:00:09 $3.8112 5
    08:00:08 $3.9688 3
    08:00:08 $3.9688 100
    08:00:06 $3.9688 12
  • S
    Sat
    This company should be sold. There are companies that would be interested in purchasing it for its tech.
  • c
    capt
    A dozen men with no monkeypox symptoms tested positive for the virus, raising questions about asymptomatic spread

    https://news.yahoo.com/dozen-men-no-monkeypox-symptoms-215213606.html
    Bullish
  • R
    Roy
    Several ambulance chasing, bottom feeding law firms are angling for Co-Dx investors who make the claim they lost money between May 12, 2022 and August 11, 2022 due to supposedly false and misleading statements about sales demand of the Logix Smartâ„¢ COVID-19 Test beyond Q1 2022. These legal claims are absolutely and totally unfounded. Co-Dx has been completely open about potential unpredictable changes in the market that could affect the Logix Smartâ„¢ COVID-19 Test future demand during the remainder of 2022 as is plainly demonstrated in statements presented in the Co-Dx May 13, 2022 Q1 Earnings Results Conference Call Transcript which includes the statement, "Our ability to accurately forecast Logix Smart COVID-19 test sales through the balance of the year has diminished." You be the judge.
    ----------
    Schall Law Firm, Kaplan Fox & Kilsheimer LLP, Rosen Law Firm - This is what the lawyers are claiming:
    "According to the Complaint, the Company made false and misleading statements to the market. Co-Diagnostics suffered from a sharp drop in demand for its Logix Smartâ„¢ COVID-19 Test, a problem that persisted throughout the quarter ending June 30, 2022. Despite this drop in demand, the Company made positive statements about the consumer demand for its product. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Co-Diagnostics, investors suffered damages."
    "Investors who purchased the Company's securities between May 12, 2022 and August 11, 2022, inclusive (the "Class Period"), are encouraged to contact the firm before October 17, 2022."
    https://www.einnews.com/pr_news/586431283/shareholder-action-alert-the-schall-law-firm-encourages-investors-in-co-diagnostics-inc-with-losses-of-100-000-to-contact-the-firm
    ----------
    From the Co-Diagnostics 05/13/2022 Q1 Earnings Results Conference Call Transcript -

    Brian Brown, CFO -
    "As we look to the balance of fiscal 2022, we remain encouraged by the demand for our products and the operational and scientific teams we have established to support our future growth.

    Turning now to our visibility around the outlook for the balance of the year.

    While we experienced strong demand for our products during the first quarter of 2022, changes in our operating environment and markets have restricted our near term visibility.

    We will continue to navigate the near term environment with caution, but as a result, we'll not be providing quarterly guidance at this time. To be clear, we remain very confident about the long-term potential of our business and the demand for our products.

    Our ability to accurately forecast Logix Smart COVID-19 test sales through the balance of the year has diminished due to decreased mask mandates in the United States, continued emergence and spread of new variants and persistently low vaccination rates in many parts of the world. Furthermore, we are experiencing sizable fluctuations in order patterns from our customers that are not cleanly captured in a particular quarter as testing requirements continue to vary across the many geographic regions we serve.

    As a result, it has become difficult to predict with an expected level of precision the cumulative impact of these and other factors on our future financial results. Despite these dynamics, we continue to believe that we are at an important point in our growth trajectory that will enable us to expand into new verticals, new markets and innovative molecular diagnostic solutions, such as our forthcoming Co-Dx PCR home testing platform. With that, I'll turn the presentation back over to Dwight."
    ----------
    Yi Chen, H.C. Wainwright -
    "So with the Logix Smart detection test, are you already seeing a decline in customer orders? Or are you refraining from providing a guidance mainly because it's tough to like predict the environment moving forward? And in the same context, I was wondering if you could, I know you spoke about it during your prepared remarks, but I was wondering if you could essentially summarize how you could leverage your CoPrimer technology for other indications, assuming COVID-19 testing decreases throughout the rest of this year?"

    Brian Brown, CFO -
    "Yes. This is Brian. I can respond to the first question that you asked. It's more about the timing and being able to forecast the timing of orders is the bigger issue. It's not necessarily a demand issue that we're seeing. It's more of just timing of being able to accurately forecast what's coming in. And the last thing we want to do is provide guidance that we're not confident in.

    And so that's one thing you'll know going forward is if we're not confident in providing guidance, then we won't provide guidance."
    ----------
  • D
    David
    According to CODX financial data submitted to the SEC, stock-based compensation to management was $2.9 million in the first half of 2022, including nearly $1.6 million in the second quarter. And why did directors sell their stock immediately after exercising stock options last quarter?
  • c
    capt
    5 Dangers of Getting Reinfected with COVID, According to Infectious Disease Specialist

    https://news.yahoo.com/5-dangers-getting-reinfected-covid-121503476.html
    Bullish
  • c
    capt
    COVID-19 May Have Long-Term Effects on the Brain

    https://news.yahoo.com/covid-19-may-long-term-204709470.html
    Bullish
  • x
    xu
    Co-Dx is now going thru another roller-coaster ride ..
    Expect the expected ..
    Expect the unexpected ..

    Lawsuits soon all make no cases as it is proven all market driven with high risks ..
    As long as company is in full compliance not in any violations ..
    Same for CDC-FDA for rules and regulations ..
    Sure many ambulance chasers trying to allure so-called class lawsuits but ..
    That is very much the market unless SCAM like DECN ..
  • R
    Roy
    Aug 17 short volumes: CODX 63%, FLGT 74%, HLTH 54%, QDEL 59%. More than 63% of the total Aug 17 CODX trade volume involved short selling including the additional involvement of short sellers covering shares from prior short sales. In addition, I observed numerous manipulative CODX trades of 1 to 5 shares and trades with strange odd share prices such as $4.0588 or $4.0112 suggesting the use of identification codes to enable illegal manipulative "matched order" and "washed" trades. There is no question that illegal manipulation determined the Aug 17 CODX share price decline.
  • X
    XZ
    Any chance of this going back to at least $6?
  • x
    xu
    Organization mistakes.. what missed ..
    Solutions Driven .. Transparency-Efficiency Accountability-Reliability ..
    Virus travels "troubles" .. curb-stop-end spreading mutations new strains ..
    Test-Early .. Treat-Early ..
    ID positive no false-negative quarantine-isolate Curb-Stop-End virus from host-to-hosts ..

    //
    A shake-up at the CDC is intended to make it a more nimble organization
    August 18, 20225:04 AM ET
    Heard on Morning Edition

    //
  • E
    Errikos
    Like all of us i was shocked by the drop in revenue. at the same time i was surprised that the dropped was not larger, why $5M of revenue was the question is asked myself. The next question was what is the break even, if we assume an average selling price of 7USD and a gross margin of 70% then the monthly units they need to sell to break even is around 142K, that is not a lot. (2.1M loss / 4.9USD / 3 as it was a quarterly loss).
  • c
    capt
    CDC director orders reorganization, saying COVID-19 response 'did not reliably meet expectations'

    https://news.yahoo.com/cdc-director-orders-reorganization-saying-163053106.html
    Bearish
  • c
    capt
    Silent crisis of soaring excess deaths gripping Britain is only tip of the iceberg

    https://news.yahoo.com/silent-crisis-soaring-excess-deaths-203000182.html
    Bullish
  • c
    capt
    Bullish
  • c
    capt
    Codx has 96 million cash in the bank and no debt and new product on the way . Hold them shorts see how that works out.
    Bullish
  • S
    Sd
    Decn. 0001 , congrats ksea
Advertisement
Advertisement